TCVâ116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats
Keywords: TCV-116; angiotensin II receptor antagonist; cardiac hyperthrophy;